Identification of human in vitro metabolites of the haemoglobin S polymerization inhibitor voxelotor for doping control purposes.
Sign Up to like & getrecommendations! Published in 2023 at "Drug testing and analysis"
DOI: 10.1002/dta.3489
Abstract: Voxelotor (GBT440) is a haemoglobin S polymerization inhibitor used to treat anaemia in sickle cell disease. Due to an increase of arterial oxygen saturation as well as serum erythropoietin and haemoglobin, the World Anti-Doping Agency… read more here.
Keywords: vitro metabolites; haemoglobin polymerization; doping control; polymerization inhibitor ... See more keywords